{"symbol":"ABBV","fiscalQuarter":"Q4-2019","reportDate":"2020-02-07","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2019","postBrief":{"headline":"AbbVie Misses on EPS, Stock Up 5.86%","keyNumbers":[{"metric":"EPS","actual":"$2.21","expected":"N/A","surprise":"-1.33%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing strength in key product lines.","They noted the importance of upcoming product launches for future growth."],"summary":"Overall, management expressed confidence in their pipeline and future prospects despite missing EPS expectations. They emphasized the strength of their existing products."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising 5.86%. Investors may be encouraged by management's focus on product strength and future launches, which could drive growth despite the EPS miss.","metaDescription":"AbbVie Inc (ABBV) Q4 2019 earnings: EPS missed expectations. Stock up 5.86%. Full breakdown."}}